Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06207864 · ClinicalTrials.gov registry record · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
A NA study of Malignant Neoplasm, sponsored by New Mexico Cancer Research Alliance.
- Recruiting
- Registry status
- NA
- Development phase
- 1,001
- Enrollment target
- 1
- Study location
NCT06207864: Recruiting NA study of Malignant Neoplasm, sponsored by New Mexico Cancer Research Alliance.
NCT06207864 is a NA study of Malignant Neoplasm that is actively recruiting participants, run by New Mexico Cancer Research Alliance. The registered enrollment target is 1,001 participants, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06207864, a NA study of Malignant Neoplasm, is actively recruiting participants, sponsored by New Mexico Cancer Research Alliance.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,001 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.
Primary Outcome
Number and percent of eligible participants enrolled and consented
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- PROCEDURE Return of Results
Study Locations (1)
New Mexico
- University of New Mexico Comprehensive Cancer Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,001 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT06207864 shows while recruiting
NCT06207864 is an interventional study that assigns participants to a tested intervention. Its 1,001 participants enrollment target places it among the larger protocols in the corpus, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher).
The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT06207864 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06207864 about?
NCT06207864 is a clinical study titled "Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing". This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. America...
What is the current status of trial NCT06207864?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,001 participants. The study started on 2022-03-22. Estimated completion is 2030-12-31.
What conditions does trial NCT06207864 study?
This clinical trial studies the following conditions: Malignant Neoplasm.
What interventions are being tested in trial NCT06207864?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Return of Results (PROCEDURE).
Who is sponsoring clinical trial NCT06207864?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06207864 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06207864's enrollment target sits among peer trials
1,001 5th of 59 higher than 55 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
-
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI